Diffusing Alpha Emitters Radiation Therapy (DART) Brachytherapy for Recurrent and Radio-Resistant Head and Neck and Skin Cancer: A New Treatment Concept
The first clinical trial in humans with skin and oral cavity squamous cell carcinoma (SCC) was performed in order to evaluate the effect of a unique intratumoral alpha radiation-based tumor ablation treatment termed Diffusing Alpha emitters Radiation Therapy (DaRT).
Source: Brachytherapy - Category: Cancer & Oncology Authors: Aron Popovtzer, Eli Rosenfeld, Aviram Mizrachy, Ran Ben Hur, Salvatore Bellia, Giacomo Feliciani, Yona Keisari Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Head and Neck Cancer | Oral Cancer | Oral Cavity Cancer | Radiation Therapy | Skin | Skin Cancer | Squamous Cell Carcinoma